Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 45 clinical trials
A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

The main purpose of this study is to measure the amount of lopinavir/ritonavir (two anti-HIV medications) in the blood. Results from this study will be compared to the levels of the drugs

kaletra
HIV Vaccine
lopinavir
ritonavir
lopinavir/ritonavir
  • 340 views
  • 08 Nov, 2020
  • 57 locations
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a

Two LNF-containing regimens will be evaluated in the D-LIVR Phase 3 study: (1) LNF/RTV/PEG IFN-alfa-2a and (2) LNF/RTV. Each of these arms will have efficacy endpoints that measure clinical benefit with regard to viral suppression and alanine aminotransferase (ALT) normalization. For each LNF-containing regimen, a composite endpoint of EOT (48 …

  • 242 views
  • 24 Mar, 2021
  • 178 locations
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

The purpose of this study is to see if emtricitabine is safe in children infected with HIV and to determine the best dose.

stavudine
lopinavir
lamivudine
emtricitabine
ritonavir
  • 151 views
  • 07 Nov, 2020
  • 2 locations
Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants

The purpose of this study is to estimate the effect of a strong inhibitor of CYP3A4 (itraconazole) on the pharmacokinetics (PK) of PF-07321332/ritonavir in healthy participants.

  • 0 views
  • 04 Aug, 2021
  • 1 location
Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients

/Ritonavir for treatment of triple class failure in adult HIV-1 infected subjects. The purpose of this study is to look at the safety and efficacy of a combination of 3 new antiretroviral drugs

maraviroc
antiviral
oophorectomy
reverse transcriptase inhibitor
elisa
  • 24 views
  • 08 Nov, 2020
  • 1 location
Evaluate the Safety Tolerability and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

The experiment is divided into two parts: Part 1 and Part 2.Part 1 was the initial treatment patient and Part 2 was the treated patient.

  • 4 views
  • 24 Jan, 2021
  • 37 locations
HIV Antiretroviral Drugs and Metabolism

Hypothesis 1: Ritonavir-based regimens increase triglycerides and VLDL by both increasing VLDL production and decreasing VLDL clearance. Specific Aim 1A: To quantify the effect of

efavirenz
lopinavir
antiretroviral agents
ritonavir
atazanavir
  • 6 views
  • 07 Nov, 2020
  • 1 location
Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-na ve Patients With Chronic Hepatitis C Genotype 1

Multicenter, open-label, phase II safety and efficacy study of all-oral combination of narlaprevir/ritonavir and sofosbuvir in Treatment-nave Patients with Chronic Hepatitis C Genotype 1.

  • 0 views
  • 23 Jan, 2021
  • 5 locations
PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Ritonavir boosted protease inhibitor based therapy will have equivalent antiviral efficacy over 48 weeks compared to NNRTI based therapy in patients who are antiretroviral therapy naïve

efavirenz
antiviral
protease
zidovudine
antiretroviral therapy
  • 42 views
  • 07 Nov, 2020
  • 5 locations
IFN Beta-1b and Ribavirin for Covid-19

As of 1 July 2020, more than 10 million people been confirmed to have infected by SARS-CoV-2, resulting in more than 500,000 deaths. No specific antiviral treatment for the SARS-CoV-2 is currently available, but existing medication could be repurposed. The investigators therefore propose to conduct an open-label randomized controlled trial …

interferon
SARS
critical illness
antiviral drugs
  • 0 views
  • 24 Jan, 2021
  • 1 location